Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (601-610 of 626) with videos related to

Pageof 63
Sort By:
Journal of Medicinal Chemistry|July 26, 2019
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of OsteoporosisAhmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger, et al.
Bioorganic & Medicinal Chemistry|December 7, 2007
Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structureCarsten Jagusch, Matthias Negri, Ulrike E Hille, et al.
ACS Medicinal Chemistry Letters|December 17, 2021
17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung CancerEmanuele M Gargano, Abdelrahman Mohamed, Ahmed S Abdelsamie, et al.
Journal of Evaluation in Clinical Practice|January 10, 2018
How the dual process model of human cognition can inform efforts to de-implement ineffective and harmful clinical practices: A preliminary model of unlearning and substitutionChristian D Helfrich, Adam J Rose, Christine W Hartmann, et al.
The Journal of Pathology|October 16, 2008
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcomaN Friedrichs, J Küchler, E Endl, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2015
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reportingE Wardelmann, R L Haas, J V M G Bovée, et al.
European Journal of Medicinal Chemistry|January 9, 2020
Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibioticsCharlotte Grandclaudon, N V Suryanarayana Birudukota, Walid A M Elgaher, et al.
Angewandte Chemie (International Ed. in English)|April 4, 2020
Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm InfectionsDuy-Khiet Ho, Xabier Murgia, Chiara De Rossi, et al.
Journal of Medicinal Chemistry|February 21, 2022
<i>N</i>-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-LactamasesCansu Kaya, Jelena Konstantinović, Andreas M Kany, et al.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
Pageof 63

Showing results (601-610 of 626) with videos related to

Sort By:
Pageof 63
Journal of Medicinal Chemistry|July 26, 2019
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of OsteoporosisAhmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger, et al.
Bioorganic & Medicinal Chemistry|December 7, 2007
Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structureCarsten Jagusch, Matthias Negri, Ulrike E Hille, et al.
ACS Medicinal Chemistry Letters|December 17, 2021
17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung CancerEmanuele M Gargano, Abdelrahman Mohamed, Ahmed S Abdelsamie, et al.
Journal of Evaluation in Clinical Practice|January 10, 2018
How the dual process model of human cognition can inform efforts to de-implement ineffective and harmful clinical practices: A preliminary model of unlearning and substitutionChristian D Helfrich, Adam J Rose, Christine W Hartmann, et al.
The Journal of Pathology|October 16, 2008
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcomaN Friedrichs, J Küchler, E Endl, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2015
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reportingE Wardelmann, R L Haas, J V M G Bovée, et al.
European Journal of Medicinal Chemistry|January 9, 2020
Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibioticsCharlotte Grandclaudon, N V Suryanarayana Birudukota, Walid A M Elgaher, et al.
Angewandte Chemie (International Ed. in English)|April 4, 2020
Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm InfectionsDuy-Khiet Ho, Xabier Murgia, Chiara De Rossi, et al.
Journal of Medicinal Chemistry|February 21, 2022
<i>N</i>-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-LactamasesCansu Kaya, Jelena Konstantinović, Andreas M Kany, et al.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
Pageof 63